middle.news
Anteris Launches Global Trial for Innovative DurAVR Heart Valve
9:42am on Thursday 16th of October, 2025 AEDT
•
Healthcare
Read Story
Anteris Launches Global Trial for Innovative DurAVR Heart Valve
9:42am on Thursday 16th of October, 2025 AEDT
Key Points
Danish Medicines Agency approves start of PARADIGM Trial
Patient recruitment to begin in Denmark Q4 2025
Trial compares DurAVR THV to existing commercial TAVR devices
Planned expansion to US, Europe, and Canada
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
AVR
OPEN ARTICLE